Cross Country Healthcare (CCRN)

• Market cap: $465M
• 1 day: -0.91%
• 5 days: -2.15%
• 1 month: -5.42%
• 3 months: -22.41%
• 6 months: 17.55%
• Year to date: -22.23%
• 1 year: -16.98%
• 5 years: 152.32%
• 10 years: 27.41%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Employees: 2,300

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

56% more call options, than puts

Call options by funds: $239K | Put options by funds: $153K

22% more capital invested

Capital invested by funds: $469M [Q3] → $574M (+$105M) [Q4]

4% less funds holding

Funds holding: 179 [Q3] → 172 (-7) [Q4]

4.68% less ownership

Funds ownership: 102.6% [Q3] → 97.92% (-4.68%) [Q4]

11% less first-time investments, than exits

New positions opened: 50 | Existing positions closed: 56

41% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 66

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $18.61 32% upside
• Avg. target: $18.61 32% upside
• High target: $18.61 32% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Barrington Research Kevin Steinke 18% 1-year accuracy 12 / 66 met price target

32% upside $18.61

Market Perform Maintained

14 Mar 2025